NASDAQ:ACHL
Achilles Therapeutics
- Stock
Last Close
0.95
25/09 14:38
Market Cap
34.51M
Beta: 0.94
Volume Today
123.01K
Avg: 193.80K
PE Ratio
−0.53
PFCF: −15.51
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 1.13M - | 3.45M 204.64% | 4.88M 41.59% | 2.31M 52.61% | ||
average payables | 3.61M - | 5.02M 39.08% | 4.45M 11.23% | 2.59M 41.78% | ||
average receivables | 5.91M - | 9.26M 56.55% | 13.59M 46.80% | 13.18M 3.02% | ||
book value per share | 61.72 - | 4.66 92.45% | 10.10 116.74% | 5.03 50.17% | 3.56 29.25% | |
capex per share | -0.57 - | -0.29 49.17% | -0.27 8.65% | -0.19 27.96% | -0.03 85.61% | |
capex to depreciation | -3.12 - | -15.35 391.98% | -2.32 84.87% | -2.04 12.32% | -0.23 88.54% | |
capex to operating cash flow | 0.07 - | 0.47 604.32% | 0.13 72.55% | 0.13 2.01% | 0.02 82.01% | |
capex to revenue | ||||||
cash per share | 59.44 - | 4.38 92.63% | 9.29 112.28% | 4.43 52.35% | 3.29 25.70% | |
days of inventory on hand | 0.00 - | |||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 0.00 - | 0.07 1,477.19% | 0.04 47.05% | 0.04 0.67% | 0.02 43.68% | |
debt to equity | 0.00 - | 0.08 1,656.42% | 0.04 49.83% | 0.04 2.79% | 0.02 42.89% | |
dividend yield | ||||||
earnings yield | -0.51 - | -0.05 90.41% | -0.43 761.85% | -2.02 374.76% | -1.97 2.60% | |
enterprise value | -69.93M - | 510.42M 829.88% | -110.50M 121.65% | -129.54M 17.23% | -91.39M 29.45% | |
enterprise value over ebitda | 5.19 - | -15.49 398.40% | 1.81 111.71% | 1.73 4.41% | 1.14 34.34% | |
ev to operating cash flow | 4.95 - | -20.21 508.76% | 1.86 109.22% | 2.18 16.73% | 1.88 13.64% | |
ev to sales | ||||||
free cash flow per share | -9.19 - | -0.91 90.06% | -2.34 155.71% | -1.71 26.65% | -1.24 27.36% | |
free cash flow yield | -0.56 - | -0.06 90.06% | -0.47 744.70% | -1.90 308.33% | -1.40 26.46% | |
graham net net | 59.29 - | 3.81 93.58% | 8.71 128.83% | 4.20 51.81% | 3.01 28.37% | |
graham number | 108.78 - | 9.26 91.49% | 22.02 137.80% | 14.35 34.81% | 11.84 17.50% | |
income quality | 1.01 - | 0.76 24.75% | 0.97 27.57% | 0.84 13.79% | 0.70 16.86% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | -0.00 Infinity% | |
interest coverage | 10.71 - | |||||
interest debt per share | 0.30 - | 0.39 32.66% | 0.43 8.73% | 0.03 92.49% | 0.09 175.45% | |
inventory turnover | 4.73M - | |||||
invested capital | 0.00 - | 0.08 1,656.42% | 0.04 49.83% | 0.04 2.79% | 0.02 42.89% | |
market cap | 27.17M - | 672.29M 2,374.01% | 143.56M 78.65% | 35.23M 75.46% | 35.54M 0.88% | |
net current asset value | 99.20M - | 158.25M 59.52% | 257.17M 62.51% | 173.27M 32.63% | 126.55M 26.96% | |
net debt to ebitda | 7.21 - | 4.91 31.85% | 4.17 15.08% | 2.21 47.12% | 1.58 28.30% | |
net income per share | -8.52 - | -0.82 90.41% | -2.13 160.90% | -1.82 14.71% | -1.75 3.79% | |
operating cash flow per share | -8.61 - | -0.62 92.78% | -2.07 232.82% | -1.52 26.48% | -1.22 20.01% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | ||||||
return on tangible assets | -0.13 - | -0.15 14.04% | -0.19 27.05% | -0.32 67.64% | -0.43 34.10% | |
revenue per share | ||||||
roe | -0.14 - | -0.18 27.00% | -0.21 20.37% | -0.36 71.17% | -0.49 35.99% | |
roic | -0.13 - | -0.15 13.20% | -0.20 34.22% | -0.37 79.19% | -0.51 39.87% | |
sales general and administrative to revenue | ||||||
shareholders equity per share | 61.72 - | 4.66 92.45% | 10.10 116.74% | 5.03 50.17% | 3.56 29.25% | |
stock based compensation to revenue | ||||||
tangible asset value | 101.35M - | 189.37M 86.85% | 289.53M 52.89% | 197.04M 31.94% | 142.37M 27.75% | |
tangible book value per share | 61.72 - | 4.66 92.45% | 10.10 116.74% | 5.03 50.17% | 3.56 29.25% | |
working capital | 99.20M - | 171.17M 72.55% | 265.64M 55.19% | 178.59M 32.77% | 128.64M 27.97% |
All numbers in USD (except ratios and percentages)